WallStreetZenWallStreetZen

NASDAQ: IGMS
Igm Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for IGMS

Based on 6 analysts offering 12 month price targets for Igm Biosciences Inc.
Min Forecast
$11.00+42.49%
Avg Forecast
$20.67+167.71%
Max Forecast
$37.00+379.27%

Should I buy or sell IGMS stock?

Based on 6 analysts offering ratings for Igm Biosciences Inc.
Buy
Strong Buy
1 analysts 16.67%
Buy
2 analysts 33.33%
Hold
3 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IGMS stock forecasts and price targets.

IGMS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Truist Securities
Bottom 9%
9
Strong BuyReiterates$25.00+223.83%2023-09-06
RBC Capital
Top 7%
94
HoldReiterates$11.00+42.49%2023-08-17
HC Wainwright & Co.
Bottom 1%
1
BuyMaintains$17.00+120.21%2023-08-07
Morgan Stanley
Top 19%
82
HoldMaintains$15.00+94.30%2023-08-07
Wedbush
Bottom 6%
6
BuyReiterates$37.00+379.27%2023-06-05
JP Morgan
Bottom 4%
4
HoldMaintains$19.00+146.11%2023-05-16

1 of 1

Forecast return on equity

Is IGMS forecast to generate an efficient return?
Company
N/A
Industry
0.6%
Market
28.78%

Forecast return on assets

Is IGMS forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.1%

IGMS revenue growth forecast

How is IGMS forecast to perform vs Biotechnology companies and vs the US market?
Company
292.5%
Industry
35.17%
Market
8.14%
IGMS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IGMS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IGMS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IGMS$7.72$20.67+167.71%Buy
JANX$9.94$29.50+196.78%Buy
AGEN$1.15$8.12+606.09%Strong Buy
URGN$15.44$31.33+102.93%Buy
CRBU$4.91$23.00+368.43%Strong Buy
View Top Biotech Stocks

Igm Biosciences Stock Forecast FAQ

Is Igm Biosciences Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: IGMS) stock is to Buy IGMS stock.

Out of 6 analysts, 1 (16.67%) are recommending IGMS as a Strong Buy, 2 (33.33%) are recommending IGMS as a Buy, 3 (50%) are recommending IGMS as a Hold, 0 (0%) are recommending IGMS as a Sell, and 0 (0%) are recommending IGMS as a Strong Sell.

If you're new to stock investing, here's how to buy Igm Biosciences stock.

What is IGMS's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: IGMS) forecast ROE is N/A, which is considered weak.

What is IGMS's Price Target?

According to 6 Wall Street analysts that have issued a 1 year IGMS price target, the average IGMS price target is $20.67, with the highest IGMS stock price forecast at $37.00 and the lowest IGMS stock price forecast at $11.00.

On average, Wall Street analysts predict that Igm Biosciences's share price could reach $20.67 by Sep 6, 2024. The average Igm Biosciences stock price prediction forecasts a potential upside of 167.71% from the current IGMS share price of $7.72.

What is IGMS's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: IGMS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.1%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.